LWBK1006-19 LWW-Govindan-Review December 7, 2011 21:24
220 DeVita, Hellman, and Rosenberg’s CANCER: Principles and Practice of Oncology Review
Question 19.15. A previously healthy 32-year-old man presents with fatigue and vague
chest discomfort. A chest radiograph shows a widened mediastinum, and
the CT scan confirms a large anterior mediastinal mass with focal areas
of hemorrhage that fills the substernal space and invades into the upper
lobe of the left lung. Laboratory studies show LDH of 850 IU/L (normal,
120–240 IU/L),-fetoprotein of 8700 ng/mL (normal,<8 ng/mL), and
-hCG of 220 mIU/mL (normal,<5 mIU/mL). Biopsy confirms embry-
onal carcinoma with elements of choriocarcinoma. After four cycles of
cisplatin, etoposide, and bleomycin, a CT scan shows marked shrinkage
of the mediastinal mass, now measuring 3 cm in maximal diameter. One
month after completion of therapy, LDH is 150 IU/L,-fetoprotein is
5.0 ng/mL, and-hCG 2.4 is mIU/mL. Which of the following is the
most appropriate management of this patient?
A. Clinical surveillance
B. Cisplatin, ifosfamide, and vinblastine (VIP)
C. Two additional cycles of cisplatin, etoposide, and bleomycin
D. Resection of the residual mediastinal mass
Question 19.16. A 22-year-old man has a retrosternal mass identified on a chest radiograph
done during his enlistment into military service. He is an asymptomatic
nonsmoker with no significant medical history. CT scan shows a 2.5-cm
smooth anterior mediastinal mass without local invasion. Serum LDH,
-hCG, and-fetoprotein are normal. Testicular ultrasound is normal.
He refuses primary surgical resection, and a percutaneous core biopsy
shows pure seminoma. Which of the following is the most appropriate
management of this patient?
A. Surgical resection
B. Radiotherapy
C. Cisplatin, etoposide, and bleomycin
D. Cisplatin plus etoposide followed by surgical resection
Question 19.17. An increased incidence of hematologic malignancies, such as acute
megakaryocytic leukemia, has been reported with which of the following
mediastinal tumors?
A. Seminoma
B. NSGCT
C. Malignant schwannoma
D. Thymic carcinoid